Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 2-5 June 2025
PRAC concludes eye condition NAION is a very rare side effect of semaglutide medicinesTreatment with semaglutide should be stopped if NAION occursEMA’s safety committee (PRAC) has…, Agenda Agenda of the PRAC meeting 2-5 June 2025DraftReference Number: EMA/PRAC/168514/2025 English (EN…, PRAC statistics: June 2025 , PRAC statistics: June 2025 English (EN) (33.18 MB - PDF)First published: 06/06/2025View, Glossary Safety signal assessments. A safety signal is information which suggests a new potentially causal association, or a new aspect of a known association…
PRAC concludes eye condition NAION is a very rare side effect of semaglutide medicinesTreatment with semaglutide should be stopped if NAION occursEMA’s safety committee (PRAC) has…, Agenda Agenda of the PRAC meeting 2-5 June 2025DraftReference Number: EMA/PRAC/168514/2025 English (EN…, PRAC statistics: June 2025 , PRAC statistics: June 2025 English (EN) (33.18 MB - PDF)First published: 06/06/2025View, Glossary Safety signal assessments. A safety signal is information which suggests a new potentially causal association, or a new aspect of a known association…
